AI
Thursday, April 08, 2010 10:16:49 PM
FDA QCOR May 4 & June 11, 2010--
from 14 Bio....
May 21 $10 .25/.35
Questcor Pharmaceuticals (QCOR)
Drug/indication: Acthar for infantile spasms
Approval decision date: June 11
Prior to the FDA's approval decision date, an FDA advisory panel will review the safety and efficacy of Acthar on May 6. The FDA's review of Acthar is expected to post to the agency's web site on May 4 or May 5.
from 14 Bio....
May 21 $10 .25/.35
Questcor Pharmaceuticals (QCOR)
Drug/indication: Acthar for infantile spasms
Approval decision date: June 11
Prior to the FDA's approval decision date, an FDA advisory panel will review the safety and efficacy of Acthar on May 6. The FDA's review of Acthar is expected to post to the agency's web site on May 4 or May 5.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
